← Back to Discover
SILVERARC CAPITAL MANAGEMENT, LLC
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $962,154,050
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ASCENDIS PHARMA A/S · ORD SHS · K08588103 · shares: $55,006,732
- CELCUITY INC · COM · 15102K100 · shares: $52,414,202
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $49,563,361
- UROGEN PHARMA LTD · COM · M96088105 · shares: $47,912,827
- IMMUNOME INC · COM · 45257U108 · shares: $42,740,421
- DIANTHUS THERAPEUTICS INC · COM · 252828108 · shares: $38,017,200
- RHYTHM PHARMACEUTICALS INC · COM · 76243J105 · shares: $34,581,515
- ORUKA THERAPEUTICS INC · COM · 687604108 · shares: $33,576,166
- MONTE ROSA THERAPEUTICS INC · COM · 61225M102 · shares: $26,820,739
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $26,546,565
Reported holdings
73 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 206,234 shares | $55,006,732 |
| CELCUITY INC | COM | 15102K100 | — | 500,996 shares | $52,414,202 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 1,280,707 shares | $49,563,361 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 1,301,979 shares | $47,912,827 |
| IMMUNOME INC | COM | 45257U108 | — | 2,017,009 shares | $42,740,421 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 390,000 shares | $38,017,200 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 311,461 shares | $34,581,515 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 352,802 shares | $33,576,166 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 1,108,295 shares | $26,820,739 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,214,390 shares | $26,546,565 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 489,382 shares | $24,836,137 |
| IMMUNOVANT INC | COM | 45258J102 | — | 619,096 shares | $23,853,769 |
| ERASCA INC | COM | 29479A108 | — | 1,263,026 shares | $23,138,636 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 2,927,698 shares | $22,631,106 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 169,593 shares | $22,599,963 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 65,679 shares | $21,988,672 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 546,256 shares | $21,282,134 |
| ARK ETF TR | PUT | 00214Q952 | PUT | 500,000 shares | $21,030,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 400,000 shares | $18,816,000 |
| VERACYTE INC | COM | 92337F107 | — | 318,001 shares | $18,676,199 |
| SYNDAX PHARMACEUTICALS INC | CALL | 87164F905 | CALL | 693,600 shares | $15,162,096 |
| GUARDANT HEALTH INC | COM | 40131M109 | — | 99,826 shares | $14,976,895 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 3,032,060 shares | $14,159,720 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 509,789 shares | $12,938,445 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 678,095 shares | $12,646,472 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | G4444S107 | — | 1,177,821 shares | $12,532,015 |
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | — | 5,744,757 shares | $11,891,647 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 95,000 shares | $11,679,300 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 186,821 shares | $11,276,516 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 330,487 shares | $10,879,632 |
| BIOGEN INC | COM | 09062X103 | — | 48,101 shares | $10,392,702 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 1,946,482 shares | $10,296,890 |
| CERUS CORP | COM | 157085101 | — | 3,472,737 shares | $10,140,392 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 500,402 shares | $9,247,429 |
| BENITEC BIOPHARMA INC | COM NEW | 08205P209 | — | 679,826 shares | $9,096,072 |
| VAXCYTE INC | COM | 92243G108 | — | 145,000 shares | $8,428,850 |
| GENEDX HOLDINGS CORP | COM CL A | 81663L200 | — | 122,269 shares | $8,393,767 |
| SAVARA INC | COM | 805111101 | — | 1,355,459 shares | $8,349,627 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 3,101,129 shares | $8,342,037 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 738,873 shares | $8,001,995 |
| ORIC PHARMACEUTICALS INC | CALL | 68622P909 | CALL | 682,600 shares | $7,392,558 |
| MONTE ROSA THERAPEUTICS INC | CALL | 61225M902 | CALL | 300,000 shares | $7,260,000 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 503,382 shares | $7,122,855 |
| COMPUGEN LTD | ORD | M25722105 | — | 3,184,257 shares | $6,814,310 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | — | 668,450 shares | $6,677,816 |
| ABIVAX SA | CALL | 00370M903 | CALL | 50,000 shares | $6,663,000 |
| IBIO INC | COM NEW | 451033708 | — | 3,520,490 shares | $6,160,858 |
| DISC MEDICINE INC | COM | 254604101 | — | 82,800 shares | $6,055,992 |
| ALKERMES PLC | SHS | G01767105 | — | 113,494 shares | $5,946,518 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 59,959 shares | $5,323,160 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 525,000 shares | $5,092,500 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 296,135 shares | $4,853,653 |
| UNIQURE NV | SHS | N90064101 | — | 105,000 shares | $4,836,300 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 360,000 shares | $3,852,000 |
| ABEONA THERAPEUTICS INC | COM NEW | 00289Y206 | — | 610,407 shares | $3,772,315 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 34,438 shares | $3,671,780 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 297,460 shares | $2,906,184 |
| KYMERA THERAPEUTICS INC | PUT | 501575954 | PUT | 25,000 shares | $2,866,750 |
| CAMP4 THERAPEUTICS CORP | COM | 13463J101 | — | 653,594 shares | $2,856,206 |
| ELUTIA INC | CL A COM | 05479K106 | — | 2,192,980 shares | $2,148,243 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 10,000 shares | $1,872,800 |
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 42,478 shares | $1,868,607 |
| ABSCI CORPORATION | PUT | 00091E959 | PUT | 157,600 shares | $1,826,584 |
| TELA BIO INC | COM | 872381108 | — | 2,137,201 shares | $1,602,901 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 227,178 shares | $1,483,472 |
| FULCRUM THERAPEUTICS INC | CALL | 359616909 | CALL | 391,900 shares | $1,434,354 |
| FRACTYL HEALTH INC | COM | 35168W103 | — | 1,637,976 shares | $1,301,208 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | — | 545,000 shares | $1,297,100 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 59,104 shares | $1,063,872 |
| CELLECTAR BIOSCIENCES INC | COM NEW | 15117F880 | — | 321,728 shares | $894,404 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 45,975 shares | $224,358 |
| ADAGIO MED HLDGS INC | COM | 00534B100 | — | 224,360 shares | $146,193 |
| ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | — | 104,828 shares | $356 |